Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cerebras Systems Inc.CBRS · Entity 3072 | Director | September 30, 2026 | October 03, 2026 |
| Lucira Health, Inc.LHDX · Entity 115613 | Director · 10% owner | June 01, 2022 | June 03, 2022 |
| Owlet, Inc.OWLT · Entity 6551 | Director · 10% owner | October 10, 2025 | October 15, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cerebras Systems Inc.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 5,292,222 |
Reported balance
After 2026-09-30 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-09-30 · Other · Disposed 1,198,489 · Balance 5,292,222 F1: Represents a pro-rata, in-kind distribution by the Eclipse Entities (as defined below) to its partners, for no additional consideration (the "Distribution"). F2: Following the distribution, consists of (i) 314,543 shares of Class A common stock held by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity Fund"); (ii) 2,573,548 shares of Class A common stock held by Eclipse SPV II, L.P. ("Eclipse SPV II"); (iii) 235,755 shares of Class A common stock held by Eclipse SPV XIII, L.P. ("Eclipse SPV XIII"); and (iv) 2,168,376 shares of Class A common stock held by Eclipse Ventures Fund I, L.P. ("Eclipse Fund," and together with Eclipse Continuity Fund, Eclipse SPV II, and Eclipse SPV XIII, "Eclipse Entities"). The Reporting Person is the sole managing member of the general partner of each of the Eclipse Entities and may be deemed to have voting, investment, and dispositive power with respect to the shares held by such entities. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 372,659 |
Reported balance
After 2026-09-30 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2026-09-30 · Other · Acquired 63,056 · Balance 372,659 F3: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. F4: The shares are held directly by an estate-planning vehicle which is controlled by the Reporting Person. |
| Class A Common StockSEC Table I · non-derivative | Direct | 420,355 |
Reported balance
After 2026-09-30 transaction · row 2
1 source rowRow 2 · 2026-09-30 · Other · Acquired 68,428 · Balance 420,355 F3: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a pro-rata, in-kind distribution by the Eclipse Entities (as defined below) to its partners, for no additional consideration (the "Distribution").
F2: Following the distribution, consists of (i) 314,543 shares of Class A common stock held by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity Fund"); (ii) 2,573,548 shares of Class A common stock held by Eclipse SPV II, L.P. ("Eclipse SPV II"); (iii) 235,755 shares of Class A common stock held by Eclipse SPV XIII, L.P. ("Eclipse SPV XIII"); and (iv) 2,168,376 shares of Class A common stock held by Eclipse Ventures Fund I, L.P. ("Eclipse Fund," and together with Eclipse Continuity Fund, Eclipse SPV II, and Eclipse SPV XIII, "Eclipse Entities"). The Reporting Person is the sole managing member of the general partner of each of the Eclipse Entities and may be deemed to have voting, investment, and dispositive power with respect to the shares held by such entities.
F3: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration.
F4: The shares are held directly by an estate-planning vehicle which is controlled by the Reporting Person.
Lucira Health, Inc.
Report date June 01, 2022 · Filed June 03, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.85 · Expires 2032-05-31 | Direct | 59,459 |
Reported balance
After 2022-06-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-06-01 · Grant · Acquired 59,459 · Balance 59,459 F1: The shares subject to this option will vest upon the earlier of the one year anniversary of the grant date of June 1, 2022 or immediately prior to the next annual meeting. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to this option will vest upon the earlier of the one year anniversary of the grant date of June 1, 2022 or immediately prior to the next annual meeting.
Owlet, Inc.
Report date October 10, 2025 · Filed October 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 5,665,669 |
Reported balance
After 2025-10-10 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2025-10-10 · Grant · Acquired 3,898,906 · Balance 5,665,669 F1: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F2: The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. The Reporting Person is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and the Reporting Person disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 968,694 |
Reported balance
Holding disclosure · report date 2025-10-10 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 968,694 F3: The securities are held of record by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. The Reporting Person, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and the Reporting Person disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 1,066,472 |
Reported balance
Holding disclosure · report date 2025-10-10 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,066,472 F4: The securities are held of record by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity I"). Eclipse Continuity GP I, LLC ("Eclipse Continuity GP") is the general partner of Eclipse Continuity I and may be deemed to have voting and dispositive power over the shares held by Eclipse Continuity I. The Reporting Person, a member of the Issuer's board of directors, is the sole managing member of Eclipse Continuity GP and may be deemed to have voting and dispositive power over the shares held by Eclipse Continuity I. Eclipse Continuity GP and the Reporting Person disclaim beneficial ownership of the shares held by Eclipse Continuity I except to the extent of their respective pecuniary interests therein, if any. |
| Series A Warrants (Right to Purchase Shares of Common Stock)SEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2025-10-10 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-10-10 · Disposition to issuer · Disposed 5,300,291 · Balance 0 F1: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F2: The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. The Reporting Person is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and the Reporting Person disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any. |
| Series B Warrants (Right to Purchase Shares of Common Stock)SEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2025-10-10 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-10-10 · Disposition to issuer · Disposed 1,166,935 · Balance 0 F1: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F2: The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. The Reporting Person is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and the Reporting Person disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.
F2: The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. The Reporting Person is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and the Reporting Person disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any.
F3: The securities are held of record by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. The Reporting Person, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and the Reporting Person disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any.
F4: The securities are held of record by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity I"). Eclipse Continuity GP I, LLC ("Eclipse Continuity GP") is the general partner of Eclipse Continuity I and may be deemed to have voting and dispositive power over the shares held by Eclipse Continuity I. The Reporting Person, a member of the Issuer's board of directors, is the sole managing member of Eclipse Continuity GP and may be deemed to have voting and dispositive power over the shares held by Eclipse Continuity I. Eclipse Continuity GP and the Reporting Person disclaim beneficial ownership of the shares held by Eclipse Continuity I except to the extent of their respective pecuniary interests therein, if any.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 3, 2026 00:21 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | OtherClass A Common Stock | 63,056 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-412337 · ownership.xml · nonDerivative · entry 3 Susan Lior · CIK 0001832895 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 372,659 F3 · kind: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. F3 · price: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. F4 · ownership.nature: The shares are held directly by an estate-planning vehicle which is controlled by the Reporting Person. Read SEC document |
| September 30, 2026 Filed Oct 3, 2026 00:21 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | OtherClass A Common Stock | 68,428 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-412337 · ownership.xml · nonDerivative · entry 2 Susan Lior · CIK 0001832895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 420,355 F3 · kind: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. F3 · price: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. Read SEC document |
| September 30, 2026 Filed Oct 3, 2026 00:21 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | OtherClass A Common Stock | 1,198,489 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-412337 · ownership.xml · nonDerivative · entry 1 Susan Lior · CIK 0001832895 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 5,292,222 F1 · kind: Represents a pro-rata, in-kind distribution by the Eclipse Entities (as defined below) to its partners, for no additional consideration (the "Distribution"). F1 · price: Represents a pro-rata, in-kind distribution by the Eclipse Entities (as defined below) to its partners, for no additional consideration (the "Distribution"). F2 · ownership.nature: Following the distribution, consists of (i) 314,543 shares of Class A common stock held by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity Fund"); (ii) 2,573,548 shares of Class A common stock held by Eclipse SPV II, L.P. ("Eclipse SPV II"); (iii) 235,755 shares of Class A common stock held by Eclipse SPV XIII, L.P. ("Eclipse SPV XIII"); and (iv) 2,168,376 shares of Class A common stock held by Eclipse Ventures Fund I, L.P. ("Eclipse Fund," and together with Eclipse Continuity Fund, Eclipse SPV II, and Eclipse SPV XIII, "Eclipse Entities"). The Reporting Person is the sole managing member of the general partner of each of the Eclipse Entities and may be deemed to have voting, investment, and dispositive power with respect to the shares held by such entities. Read SEC document |
| September 23, 2026 Filed Sep 25, 2026 20:34 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | OtherClass A Common Stock | 23,735 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-402911 · ownership.xml · nonDerivative · entry 3 Susan Lior · CIK 0001832895 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 309,603 F3 · kind: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. F3 · price: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. F5 · balance_after: This amount reflects the reported transaction and includes 7,093 shares that were inadvertently omitted from the Reporting Person's Form 4 filed on August 18, 2026 due to an administrative error. F6 · ownership.nature: The shares are held directly by an estate-planning vehicle which is controlled by the Reporting Person. Read SEC document |
| September 23, 2026 Filed Sep 25, 2026 20:34 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | OtherClass A Common Stock | 25,757 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-402911 · ownership.xml · nonDerivative · entry 2 Susan Lior · CIK 0001832895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 351,927 F3 · kind: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. F3 · price: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. F4 · balance_after: This amount reflects the reported transaction and includes 11,046 shares that were inadvertently omitted from the Reporting Person's Form 4 filed on August 18, 2026 due to an administrative error. Read SEC document |
| September 23, 2026 Filed Sep 25, 2026 20:34 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | OtherClass A Common Stock | 451,118 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-402911 · ownership.xml · nonDerivative · entry 1 Susan Lior · CIK 0001832895 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 6,490,711 F1 · kind: Represents a pro-rata, in-kind distribution by the Eclipse Entities (as defined below) to its partners, for no additional consideration (the "Distribution"). F1 · price: Represents a pro-rata, in-kind distribution by the Eclipse Entities (as defined below) to its partners, for no additional consideration (the "Distribution"). F2 · ownership.nature: Following the distribution, consists of (i) 385,774 shares of Class A common stock held by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity Fund"); (ii) 3,156,361 shares of Class A common stock held by Eclipse SPV II, L.P. ("Eclipse SPV II"); (iii) 289,144 shares of Class A common stock held by Eclipse SPV XIII, L.P. ("Eclipse SPV XIII"); and (iv) 2,659,432 shares of Class A common stock held by Eclipse Ventures Fund I, L.P. ("Eclipse Fund," and together with Eclipse Continuity Fund, Eclipse SPV II, and Eclipse SPV XIII, "Eclipse Entities"). The Reporting Person is the sole managing member of the general partner of each of the Eclipse Entities and may be deemed to have voting, investment, and dispositive power with respect to the shares held by such entities. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:16 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | OtherClass A Common Stock | 23,734 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-394365 · ownership.xml · nonDerivative · entry 3 Susan Lior · CIK 0001832895 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 278,775 F3 · kind: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. F3 · price: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. F4 · ownership.nature: The shares are held directly by an estate-planning vehicle which is controlled by the Reporting Person. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:16 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | OtherClass A Common Stock | 24,463 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-394365 · ownership.xml · nonDerivative · entry 2 Susan Lior · CIK 0001832895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 315,124 F3 · kind: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. F3 · price: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:16 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | OtherClass A Common Stock | 451,115 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-394365 · ownership.xml · nonDerivative · entry 1 Susan Lior · CIK 0001832895 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 6,941,829 F1 · kind: Represents a pro-rata, in-kind distribution by the Eclipse Entities (as defined below) to its partners, for no additional consideration (the "Distribution"). F1 · price: Represents a pro-rata, in-kind distribution by the Eclipse Entities (as defined below) to its partners, for no additional consideration (the "Distribution"). F2 · ownership.nature: Following the distribution, consists of (i) 412,586 shares of Class A common stock held by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity Fund"); (ii) 3,375,735 shares of Class A common stock held by Eclipse SPV II, L.P. ("Eclipse SPV II"); (iii) 309,240 shares of Class A common stock held by Eclipse SPV XIII, L.P. ("Eclipse SPV XIII"); and (iv) 2,844,268 shares of Class A common stock held by Eclipse Ventures Fund I, L.P. ("Eclipse Fund," and together with Eclipse Continuity Fund, Eclipse SPV II, and Eclipse SPV XIII, "Eclipse Entities"). The Reporting Person is the sole managing member of the general partner of each of the Eclipse Entities and may be deemed to have voting, investment, and dispositive power with respect to the shares held by such entities. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 20:05 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | OtherClass A Common Stock | 47,470 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-383631 · ownership.xml · nonDerivative · entry 3 Susan Lior · CIK 0001832895 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 255,041 F3 · kind: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. F3 · price: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. F4 · ownership.nature: The shares are held directly by an estate-planning vehicle which is controlled by the Reporting Person. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 20:05 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | OtherClass A Common Stock | 46,455 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-383631 · ownership.xml · nonDerivative · entry 2 Susan Lior · CIK 0001832895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 290,661 F3 · kind: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. F3 · price: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 20:05 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | OtherClass A Common Stock | 902,236 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-383631 · ownership.xml · nonDerivative · entry 1 Susan Lior · CIK 0001832895 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 7,392,944 F1 · kind: Represents a pro-rata, in-kind distribution by the Eclipse Entities (as defined below) to its partners, for no additional consideration (the "Distribution"). F1 · price: Represents a pro-rata, in-kind distribution by the Eclipse Entities (as defined below) to its partners, for no additional consideration (the "Distribution"). F2 · ownership.nature: Following the distribution, consists of (i) 439,397 shares of Class A common stock held by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity Fund"); (ii) 3,595,108 shares of Class A common stock held by Eclipse SPV II, L.P. ("Eclipse SPV II"); (iii) 329,335 shares of Class A common stock held by Eclipse SPV XIII, L.P. ("Eclipse SPV XIII"); and (iv) 3,029,104 shares of Class A common stock held by Eclipse Ventures Fund I, L.P. ("Eclipse Fund," and together with Eclipse Continuity Fund, Eclipse SPV II, and Eclipse SPV XIII, "Eclipse Entities"). The Reporting Person is the sole managing member of the general partner of each of the Eclipse Entities and may be deemed to have voting, investment, and dispositive power with respect to the shares held by such entities. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 20:15 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | OtherClass A Common Stock | 46,780 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-361120 · ownership.xml · nonDerivative · entry 3 Susan Lior · CIK 0001832895 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 207,571 F3 · kind: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. F3 · price: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. F4 · ownership.nature: The shares are held directly by an estate-planning vehicle which is controlled by the Reporting Person. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 20:15 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | OtherClass A Common Stock | 46,422 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-361120 · ownership.xml · nonDerivative · entry 2 Susan Lior · CIK 0001832895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,206 F3 · kind: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. F3 · price: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 20:15 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | OtherClass A Common Stock | 902,235 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-361120 · ownership.xml · nonDerivative · entry 1 Susan Lior · CIK 0001832895 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 8,295,180 F1 · kind: Represents a pro-rata, in-kind distribution by the Eclipse Entities (as defined below) to its partners, for no additional consideration (the "Distribution"). F1 · price: Represents a pro-rata, in-kind distribution by the Eclipse Entities (as defined below) to its partners, for no additional consideration (the "Distribution"). F2 · ownership.nature: Following the distribution, consists of (i) 493,021 shares of Class A common stock held by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity Fund"); (ii) 4,033,856 shares of Class A common stock held by Eclipse SPV II, L.P. ("Eclipse SPV II"); (iii) 369,527 shares of Class A common stock held by Eclipse SPV XIII, L.P. ("Eclipse SPV XIII"); and (iv) 3,398,776 shares of Class A common stock held by Eclipse Ventures Fund I, L.P. ("Eclipse Fund," and together with Eclipse Continuity Fund, Eclipse SPV II, and Eclipse SPV XIII, "Eclipse Entities"). The Reporting Person is the sole managing member of the general partner of each of the Eclipse Entities and may be deemed to have voting, investment, and dispositive power with respect to the shares held by such entities. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:17 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | OtherClass A Common Stock | 119,816 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-355497 · ownership.xml · nonDerivative · entry 3 Susan Lior · CIK 0001832895 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 160,791 F3 · kind: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. F3 · price: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. F4 · ownership.nature: The shares are held directly by an estate-planning vehicle which is controlled by the Reporting Person. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:17 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | OtherClass A Common Stock | 104,811 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-355497 · ownership.xml · nonDerivative · entry 2 Susan Lior · CIK 0001832895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,784 F3 · kind: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. F3 · price: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:17 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | OtherClass A Common Stock | 2,248,855 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-355497 · ownership.xml · nonDerivative · entry 1 Susan Lior · CIK 0001832895 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 9,197,415 F1 · kind: Represents a pro-rata, in-kind distribution by the Eclipse Entities (as defined below) to its partners, for no additional consideration (the "Distribution"). F1 · price: Represents a pro-rata, in-kind distribution by the Eclipse Entities (as defined below) to its partners, for no additional consideration (the "Distribution"). F2 · ownership.nature: Following the distribution, consists of (i) 546,645 shares of Class A common stock held by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity Fund"); (ii) 4,472,603 shares of Class A common stock held by Eclipse SPV II, L.P. ("Eclipse SPV II"); (iii) 409,719 shares of Class A common stock held by Eclipse SPV XIII, L.P. ("Eclipse SPV XIII"); and (iv) 3,768,448 shares of Class A common stock held by Eclipse Ventures Fund I, L.P. ("Eclipse Fund," and together with Eclipse Continuity Fund, Eclipse SPV II, and Eclipse SPV XIII, "Eclipse Entities"). The Reporting Person is the sole managing member of the general partner of each of the Eclipse Entities and may be deemed to have voting, investment, and dispositive power with respect to the shares held by such entities. Read SEC document |
| June 25, 2026 Filed Jun 26, 2026 20:49 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | OtherClass A Common Stock | 40,975 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-285632 · ownership.xml · nonDerivative · entry 3 Susan Lior · CIK 0001832895 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 40,975 F3 · kind: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. F3 · price: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. F4 · ownership.nature: The shares are held directly by an estate-planning vehicle which is controlled by the Reporting Person. Read SEC document |
| June 25, 2026 Filed Jun 26, 2026 20:49 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | OtherClass A Common Stock | 92,973 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-285632 · ownership.xml · nonDerivative · entry 2 Susan Lior · CIK 0001832895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,973 F3 · kind: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. F3 · price: The shares were obtained pursuant to a pro-rata, in-kind distribution from the Eclipse Entities, for no additional consideration. Read SEC document |
| June 25, 2026 Filed Jun 26, 2026 20:49 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | OtherClass A Common Stock | 2,019,927 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-285632 · ownership.xml · nonDerivative · entry 1 Susan Lior · CIK 0001832895 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 11,446,270 F1 · kind: Represents a pro-rata, in-kind distribution by the Eclipse Entities (as defined below) to its partners, for no additional consideration (the "Distribution"). F1 · price: Represents a pro-rata, in-kind distribution by the Eclipse Entities (as defined below) to its partners, for no additional consideration (the "Distribution"). F2 · ownership.nature: Following the distribution, consists of (i) 680,305 shares of Class A common stock held by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity Fund"); (ii) 5,566,197 shares of Class A common stock held by Eclipse SPV II, L.P. ("Eclipse SPV II"); (iii) 509,898 shares of Class A common stock held by Eclipse SPV XIII, L.P. ("Eclipse SPV XIII"); and (iv) 4,689,870 shares of Class A common stock held by Eclipse Ventures Fund I, L.P. ("Eclipse Fund," and together with Eclipse Continuity Fund, Eclipse SPV II, and Eclipse SPV XIII, "Eclipse Entities"). The Reporting Person is the sole managing member of the general partner of each of the Eclipse Entities and may be deemed to have voting, investment, and dispositive power with respect to the shares held by such entities. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 22:14 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | ConversionClass B Common Stock · Derivative | 13,466,197 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-269837 · ownership.xml · derivative · entry 2 Susan Lior · CIK 0001832895 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Class A Common Stock · 13,466,197 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. On June 11, 2026, the following shares held by the Eclipse Entities were voluntarily converted to Class A common stock: (i) 800,358 shares of Class B common stock held by Eclipse Continuity Fund, (ii) 6,548,466 shares of Class B common stock held by Eclipse SPV II, (iii) 599,880 shares of Class B common stock held by Eclipse SPV XIII, and (iv) 5,517,493 shares of Class B common stock held by Eclipse Fund. F1 · kind: Represents shares of Class A common stock that were acquired by the Reporting Person upon voluntary conversion of shares of Class B common stock. F3 · price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. On June 11, 2026, the following shares held by the Eclipse Entities were voluntarily converted to Class A common stock: (i) 800,358 shares of Class B common stock held by Eclipse Continuity Fund, (ii) 6,548,466 shares of Class B common stock held by Eclipse SPV II, (iii) 599,880 shares of Class B common stock held by Eclipse SPV XIII, and (iv) 5,517,493 shares of Class B common stock held by Eclipse Fund. F3 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. On June 11, 2026, the following shares held by the Eclipse Entities were voluntarily converted to Class A common stock: (i) 800,358 shares of Class B common stock held by Eclipse Continuity Fund, (ii) 6,548,466 shares of Class B common stock held by Eclipse SPV II, (iii) 599,880 shares of Class B common stock held by Eclipse SPV XIII, and (iv) 5,517,493 shares of Class B common stock held by Eclipse Fund. F3 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. On June 11, 2026, the following shares held by the Eclipse Entities were voluntarily converted to Class A common stock: (i) 800,358 shares of Class B common stock held by Eclipse Continuity Fund, (ii) 6,548,466 shares of Class B common stock held by Eclipse SPV II, (iii) 599,880 shares of Class B common stock held by Eclipse SPV XIII, and (iv) 5,517,493 shares of Class B common stock held by Eclipse Fund. F3 · ownership.nature: Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. On June 11, 2026, the following shares held by the Eclipse Entities were voluntarily converted to Class A common stock: (i) 800,358 shares of Class B common stock held by Eclipse Continuity Fund, (ii) 6,548,466 shares of Class B common stock held by Eclipse SPV II, (iii) 599,880 shares of Class B common stock held by Eclipse SPV XIII, and (iv) 5,517,493 shares of Class B common stock held by Eclipse Fund. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 22:14 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | ConversionClass A Common Stock | 13,466,197 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-269837 · ownership.xml · nonDerivative · entry 1 Susan Lior · CIK 0001832895 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 13,466,197 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of Class A common stock that were acquired by the Reporting Person upon voluntary conversion of shares of Class B common stock. F1 · price: Represents shares of Class A common stock that were acquired by the Reporting Person upon voluntary conversion of shares of Class B common stock. F2 · ownership.nature: Consists of (i) 800,358 shares of Class A common stock held by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity Fund"); (ii) 6,548,466 shares of Class A common stock held by Eclipse SPV II, L.P. ("Eclipse SPV II"); (iii) 599,880 shares of Class A common stock held by Eclipse SPV XIII, L.P. ("Eclipse SPV XIII"); and (iv) 5,517,493 shares of Class A common stock held by Eclipse Ventures Fund I, L.P. ("Eclipse Fund," and together with Eclipse Continuity Fund, Eclipse SPV II, and Eclipse SPV XIII, "Eclipse Entities"). The Reporting Person is the sole managing member of the general partner of each of the Eclipse Entities and may be deemed to have voting, investment, and dispositive power with respect to the shares held by such entities. Read SEC document |
| May 15, 2026 Filed May 15, 2026 22:50 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | ConversionClass B Common Stock · Derivative | 12,372,199 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-035745 · wk-form4_1778885427.xml · derivative · entry 9 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 13,466,197 Underlying: Class A Common Stock · 12,372,199 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F3 · ownership.nature: The Reporting Person is the sole managing member of the general partner of each of the Eclipse Entities and may be deemed to have voting, investment, and dispositive power with respect to the shares held by such entities. F4 · ownership.nature: Following the transactions reported herein, consists of (i) 800,358 shares of Class B common stock held by Eclipse Continuity Fund, (ii) 6,548,466 shares of Class B common stock held by Eclipse SPV II, (iii) 599,880 shares of Class B common stock held by Eclipse SPV XIII, and (iv) 5,517,493 shares of Class B common stock held by Eclipse Fund. Read SEC document |
| May 15, 2026 Filed May 15, 2026 22:50 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | ConversionSeries F Preferred Stock · Derivative | 9,010 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-035745 · wk-form4_1778885427.xml · derivative · entry 8 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Class B Common Stock · 9,010 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · derivative.underlying: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F2 · ownership.nature: Consists of (i) 486,175 shares of Class B common stock underlying Series C Preferred Stock, 309,678 shares of Class B common stock underlying Series D Preferred Stock, and 4,505 shares of Class B common stock underlying Series F Preferred Stock held by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity Fund"); (ii) 6,548,466 shares of Class B common stock underlying Series E Preferred Stock held by Eclipse SPV II, L.P. ("Eclipse SPV II"); (iii) 599,880 shares of Class B common stock held by Eclipse SPV XIII, L.P. ("Eclipse SPV XIII"); and (iv) 494,118 shares of Class B common stock, 4,419,405 shares of Class B common stock underlying Series A Preferred Stock, 599,465 shares of Class B common stock underlying Series B Preferred Stock, and 4,505 shares of Class B common stock underlying Series F Preferred Stock held by Eclipse Ventures Fund I, L.P. ("Eclipse Fund," and together with Eclipse Continuity Fund, Eclipse SPV II, and Eclipse SPV XIII, "Eclipse Entities"). F3 · ownership.nature: The Reporting Person is the sole managing member of the general partner of each of the Eclipse Entities and may be deemed to have voting, investment, and dispositive power with respect to the shares held by such entities. Read SEC document |
| May 15, 2026 Filed May 15, 2026 22:50 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | ConversionSeries E Preferred Stock · Derivative | 6,548,466 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-035745 · wk-form4_1778885427.xml · derivative · entry 7 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Class B Common Stock · 6,548,466 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · derivative.underlying: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F2 · ownership.nature: Consists of (i) 486,175 shares of Class B common stock underlying Series C Preferred Stock, 309,678 shares of Class B common stock underlying Series D Preferred Stock, and 4,505 shares of Class B common stock underlying Series F Preferred Stock held by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity Fund"); (ii) 6,548,466 shares of Class B common stock underlying Series E Preferred Stock held by Eclipse SPV II, L.P. ("Eclipse SPV II"); (iii) 599,880 shares of Class B common stock held by Eclipse SPV XIII, L.P. ("Eclipse SPV XIII"); and (iv) 494,118 shares of Class B common stock, 4,419,405 shares of Class B common stock underlying Series A Preferred Stock, 599,465 shares of Class B common stock underlying Series B Preferred Stock, and 4,505 shares of Class B common stock underlying Series F Preferred Stock held by Eclipse Ventures Fund I, L.P. ("Eclipse Fund," and together with Eclipse Continuity Fund, Eclipse SPV II, and Eclipse SPV XIII, "Eclipse Entities"). F3 · ownership.nature: The Reporting Person is the sole managing member of the general partner of each of the Eclipse Entities and may be deemed to have voting, investment, and dispositive power with respect to the shares held by such entities. Read SEC document |
| May 15, 2026 Filed May 15, 2026 22:50 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | ConversionSeries D Preferred Stock · Derivative | 309,678 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-035745 · wk-form4_1778885427.xml · derivative · entry 6 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Class B Common Stock · 309,678 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · derivative.underlying: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F2 · ownership.nature: Consists of (i) 486,175 shares of Class B common stock underlying Series C Preferred Stock, 309,678 shares of Class B common stock underlying Series D Preferred Stock, and 4,505 shares of Class B common stock underlying Series F Preferred Stock held by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity Fund"); (ii) 6,548,466 shares of Class B common stock underlying Series E Preferred Stock held by Eclipse SPV II, L.P. ("Eclipse SPV II"); (iii) 599,880 shares of Class B common stock held by Eclipse SPV XIII, L.P. ("Eclipse SPV XIII"); and (iv) 494,118 shares of Class B common stock, 4,419,405 shares of Class B common stock underlying Series A Preferred Stock, 599,465 shares of Class B common stock underlying Series B Preferred Stock, and 4,505 shares of Class B common stock underlying Series F Preferred Stock held by Eclipse Ventures Fund I, L.P. ("Eclipse Fund," and together with Eclipse Continuity Fund, Eclipse SPV II, and Eclipse SPV XIII, "Eclipse Entities"). F3 · ownership.nature: The Reporting Person is the sole managing member of the general partner of each of the Eclipse Entities and may be deemed to have voting, investment, and dispositive power with respect to the shares held by such entities. Read SEC document |
| May 15, 2026 Filed May 15, 2026 22:50 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | ConversionSeries C Preferred Stock · Derivative | 486,175 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-035745 · wk-form4_1778885427.xml · derivative · entry 5 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Class B Common Stock · 486,175 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · derivative.underlying: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F2 · ownership.nature: Consists of (i) 486,175 shares of Class B common stock underlying Series C Preferred Stock, 309,678 shares of Class B common stock underlying Series D Preferred Stock, and 4,505 shares of Class B common stock underlying Series F Preferred Stock held by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity Fund"); (ii) 6,548,466 shares of Class B common stock underlying Series E Preferred Stock held by Eclipse SPV II, L.P. ("Eclipse SPV II"); (iii) 599,880 shares of Class B common stock held by Eclipse SPV XIII, L.P. ("Eclipse SPV XIII"); and (iv) 494,118 shares of Class B common stock, 4,419,405 shares of Class B common stock underlying Series A Preferred Stock, 599,465 shares of Class B common stock underlying Series B Preferred Stock, and 4,505 shares of Class B common stock underlying Series F Preferred Stock held by Eclipse Ventures Fund I, L.P. ("Eclipse Fund," and together with Eclipse Continuity Fund, Eclipse SPV II, and Eclipse SPV XIII, "Eclipse Entities"). F3 · ownership.nature: The Reporting Person is the sole managing member of the general partner of each of the Eclipse Entities and may be deemed to have voting, investment, and dispositive power with respect to the shares held by such entities. Read SEC document |
| May 15, 2026 Filed May 15, 2026 22:50 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | ConversionSeries B Preferred Stock · Derivative | 599,465 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-035745 · wk-form4_1778885427.xml · derivative · entry 4 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Class B Common Stock · 599,465 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · derivative.underlying: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F2 · ownership.nature: Consists of (i) 486,175 shares of Class B common stock underlying Series C Preferred Stock, 309,678 shares of Class B common stock underlying Series D Preferred Stock, and 4,505 shares of Class B common stock underlying Series F Preferred Stock held by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity Fund"); (ii) 6,548,466 shares of Class B common stock underlying Series E Preferred Stock held by Eclipse SPV II, L.P. ("Eclipse SPV II"); (iii) 599,880 shares of Class B common stock held by Eclipse SPV XIII, L.P. ("Eclipse SPV XIII"); and (iv) 494,118 shares of Class B common stock, 4,419,405 shares of Class B common stock underlying Series A Preferred Stock, 599,465 shares of Class B common stock underlying Series B Preferred Stock, and 4,505 shares of Class B common stock underlying Series F Preferred Stock held by Eclipse Ventures Fund I, L.P. ("Eclipse Fund," and together with Eclipse Continuity Fund, Eclipse SPV II, and Eclipse SPV XIII, "Eclipse Entities"). F3 · ownership.nature: The Reporting Person is the sole managing member of the general partner of each of the Eclipse Entities and may be deemed to have voting, investment, and dispositive power with respect to the shares held by such entities. Read SEC document |
| May 15, 2026 Filed May 15, 2026 22:50 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | ConversionSeries A Preferred Stock · Derivative | 4,419,405 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-035745 · wk-form4_1778885427.xml · derivative · entry 3 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Class B Common Stock · 4,419,405 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · derivative.underlying: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F2 · ownership.nature: Consists of (i) 486,175 shares of Class B common stock underlying Series C Preferred Stock, 309,678 shares of Class B common stock underlying Series D Preferred Stock, and 4,505 shares of Class B common stock underlying Series F Preferred Stock held by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity Fund"); (ii) 6,548,466 shares of Class B common stock underlying Series E Preferred Stock held by Eclipse SPV II, L.P. ("Eclipse SPV II"); (iii) 599,880 shares of Class B common stock held by Eclipse SPV XIII, L.P. ("Eclipse SPV XIII"); and (iv) 494,118 shares of Class B common stock, 4,419,405 shares of Class B common stock underlying Series A Preferred Stock, 599,465 shares of Class B common stock underlying Series B Preferred Stock, and 4,505 shares of Class B common stock underlying Series F Preferred Stock held by Eclipse Ventures Fund I, L.P. ("Eclipse Fund," and together with Eclipse Continuity Fund, Eclipse SPV II, and Eclipse SPV XIII, "Eclipse Entities"). F3 · ownership.nature: The Reporting Person is the sole managing member of the general partner of each of the Eclipse Entities and may be deemed to have voting, investment, and dispositive power with respect to the shares held by such entities. Read SEC document |
| May 15, 2026 Filed May 15, 2026 22:50 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | OtherClass B Common Stock · Derivative | 1,093,998 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-035745 · wk-form4_1778885427.xml · derivative · entry 2 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 1,093,998 Underlying: Class A Common Stock · 1,093,998 shares Expires not disclosed F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · kind: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F2 · ownership.nature: Consists of (i) 486,175 shares of Class B common stock underlying Series C Preferred Stock, 309,678 shares of Class B common stock underlying Series D Preferred Stock, and 4,505 shares of Class B common stock underlying Series F Preferred Stock held by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity Fund"); (ii) 6,548,466 shares of Class B common stock underlying Series E Preferred Stock held by Eclipse SPV II, L.P. ("Eclipse SPV II"); (iii) 599,880 shares of Class B common stock held by Eclipse SPV XIII, L.P. ("Eclipse SPV XIII"); and (iv) 494,118 shares of Class B common stock, 4,419,405 shares of Class B common stock underlying Series A Preferred Stock, 599,465 shares of Class B common stock underlying Series B Preferred Stock, and 4,505 shares of Class B common stock underlying Series F Preferred Stock held by Eclipse Ventures Fund I, L.P. ("Eclipse Fund," and together with Eclipse Continuity Fund, Eclipse SPV II, and Eclipse SPV XIII, "Eclipse Entities"). F3 · ownership.nature: The Reporting Person is the sole managing member of the general partner of each of the Eclipse Entities and may be deemed to have voting, investment, and dispositive power with respect to the shares held by such entities. Read SEC document |
| May 15, 2026 Filed May 15, 2026 22:50 UTC | Cerebras Systems Inc. CBRS · Entity 3072 | OtherClass A Common Stock | 1,093,998 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-035745 · wk-form4_1778885427.xml · nonDerivative · entry 1 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 F1 · kind: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of Class A common stock was reclassified, and each share of the Issuer's redeemable convertible preferred stock automatically converted and was reclassified, into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F2 · ownership.nature: Consists of (i) 486,175 shares of Class B common stock underlying Series C Preferred Stock, 309,678 shares of Class B common stock underlying Series D Preferred Stock, and 4,505 shares of Class B common stock underlying Series F Preferred Stock held by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity Fund"); (ii) 6,548,466 shares of Class B common stock underlying Series E Preferred Stock held by Eclipse SPV II, L.P. ("Eclipse SPV II"); (iii) 599,880 shares of Class B common stock held by Eclipse SPV XIII, L.P. ("Eclipse SPV XIII"); and (iv) 494,118 shares of Class B common stock, 4,419,405 shares of Class B common stock underlying Series A Preferred Stock, 599,465 shares of Class B common stock underlying Series B Preferred Stock, and 4,505 shares of Class B common stock underlying Series F Preferred Stock held by Eclipse Ventures Fund I, L.P. ("Eclipse Fund," and together with Eclipse Continuity Fund, Eclipse SPV II, and Eclipse SPV XIII, "Eclipse Entities"). F3 · ownership.nature: The Reporting Person is the sole managing member of the general partner of each of the Eclipse Entities and may be deemed to have voting, investment, and dispositive power with respect to the shares held by such entities. Read SEC document |
| October 10, 2025 Filed Oct 15, 2025 22:51 UTC | Owlet, Inc. OWLT · Entity 6551 | Disposition to issuerSeries B Warrants (Right to Purchase Shares of Common Stock) · Derivative | 1,166,935 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-240511 · ownership.xml · derivative · entry 5 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 1,166,935 shares Expires not disclosed F1 · derivative.exercise_price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · kind: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · derivative.exercise_date: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · derivative.expiration_date: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F2 · ownership.nature: The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. The Reporting Person is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and the Reporting Person disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any. Read SEC document |
| October 10, 2025 Filed Oct 15, 2025 22:51 UTC | Owlet, Inc. OWLT · Entity 6551 | Disposition to issuerSeries A Warrants (Right to Purchase Shares of Common Stock) · Derivative | 5,300,291 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-240511 · ownership.xml · derivative · entry 4 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 5,300,291 shares Expires not disclosed F1 · derivative.exercise_price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · kind: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · derivative.exercise_date: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · derivative.expiration_date: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F2 · ownership.nature: The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. The Reporting Person is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and the Reporting Person disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any. Read SEC document |
| October 10, 2025 Filed Oct 15, 2025 22:51 UTC | Owlet, Inc. OWLT · Entity 6551 | GrantCommon Stock | 3,898,906 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-240511 · ownership.xml · nonDerivative · entry 1 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 5,665,669 F1 · kind: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F2 · ownership.nature: The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. The Reporting Person is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and the Reporting Person disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 20:03 UTC | Owlet, Inc. OWLT · Entity 6551 | ConversionSeries A Convertible Preferred Stock · Derivative | 12,120 | $1,000.00 Strike: $0.00 | $12,120,000.00 |
DisclosureSEC source: 0001628280-24-038213 · wk-form4_1724357018.xml · derivative · entry 4 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote. Disclosed balance after: 8,080 Underlying: Common Stock · 1,766,763 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: On August 20, 2024, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") converted 12,120 shares of Series A Convertible Preferred Stock of the Issuer at an exchange ratio of 145.7726, pursuant to the terms and conditions of the Investment Agreement (Excluded Investors), dated February 17, 2023, by and among the Issuer, Eclipse EGF I and the other parties thereto. The number of shares and exchange ratio have been adjusted to reflect the 1-for-14 reverse stock split the Issuer completed on July 7, 2023. F3 · shares: On August 20, 2024, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") converted 12,120 shares of Series A Convertible Preferred Stock of the Issuer at an exchange ratio of 145.7726, pursuant to the terms and conditions of the Investment Agreement (Excluded Investors), dated February 17, 2023, by and among the Issuer, Eclipse EGF I and the other parties thereto. The number of shares and exchange ratio have been adjusted to reflect the 1-for-14 reverse stock split the Issuer completed on July 7, 2023. F3 · price: On August 20, 2024, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") converted 12,120 shares of Series A Convertible Preferred Stock of the Issuer at an exchange ratio of 145.7726, pursuant to the terms and conditions of the Investment Agreement (Excluded Investors), dated February 17, 2023, by and among the Issuer, Eclipse EGF I and the other parties thereto. The number of shares and exchange ratio have been adjusted to reflect the 1-for-14 reverse stock split the Issuer completed on July 7, 2023. F5 · derivative.expiration_date: The Series A Convertible Preferred Stock does not have an expiration date. F3 · derivative.underlying_shares: On August 20, 2024, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") converted 12,120 shares of Series A Convertible Preferred Stock of the Issuer at an exchange ratio of 145.7726, pursuant to the terms and conditions of the Investment Agreement (Excluded Investors), dated February 17, 2023, by and among the Issuer, Eclipse EGF I and the other parties thereto. The number of shares and exchange ratio have been adjusted to reflect the 1-for-14 reverse stock split the Issuer completed on July 7, 2023. F4 · ownership.nature: The shares of Common Stock are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 20:03 UTC | Owlet, Inc. OWLT · Entity 6551 | ConversionCommon Stock | 1,766,763 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-038213 · wk-form4_1724357018.xml · nonDerivative · entry 3 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,766,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: On August 20, 2024, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") converted 12,120 shares of Series A Convertible Preferred Stock of the Issuer at an exchange ratio of 145.7726, pursuant to the terms and conditions of the Investment Agreement (Excluded Investors), dated February 17, 2023, by and among the Issuer, Eclipse EGF I and the other parties thereto. The number of shares and exchange ratio have been adjusted to reflect the 1-for-14 reverse stock split the Issuer completed on July 7, 2023. F4 · ownership.nature: The shares of Common Stock are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 21:31 UTC | Owlet, Inc. OWLT · Entity 6551 | PurchaseCommon Stock Warrant (Right to Buy) · Derivative | 1,166,935 | Not disclosed Strike: $7.71 | Not disclosed |
DisclosureSEC source: 0001628280-24-008526 · wk-form4_1709587530.xml · derivative · entry 4 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes. Disclosed balance after: 1,166,935 Underlying: Common Stock · 1,166,935 shares Expires 2029-03-01 F6 · derivative.exercise_price: As set forth in the Warrant to Purchase Shares of Common Stock of Owlet, Inc., dated February 29, 2024, by the Issuer and Eclipse EGF I (the "Warrant"), the exercise price and the number of shares of the Issuer's Common Stock issuable upon exercise are subject to adjustment upon the occurrence of certain events. As such, the exercise price and the number of shares of Common Stock issuable upon exercise as reported on this Form 4 are subject to change upon the occurrence of future events in accordance with the terms of the Warrant. F6 · shares: As set forth in the Warrant to Purchase Shares of Common Stock of Owlet, Inc., dated February 29, 2024, by the Issuer and Eclipse EGF I (the "Warrant"), the exercise price and the number of shares of the Issuer's Common Stock issuable upon exercise are subject to adjustment upon the occurrence of certain events. As such, the exercise price and the number of shares of Common Stock issuable upon exercise as reported on this Form 4 are subject to change upon the occurrence of future events in accordance with the terms of the Warrant. F6 · price: As set forth in the Warrant to Purchase Shares of Common Stock of Owlet, Inc., dated February 29, 2024, by the Issuer and Eclipse EGF I (the "Warrant"), the exercise price and the number of shares of the Issuer's Common Stock issuable upon exercise are subject to adjustment upon the occurrence of certain events. As such, the exercise price and the number of shares of Common Stock issuable upon exercise as reported on this Form 4 are subject to change upon the occurrence of future events in accordance with the terms of the Warrant. F6 · derivative.underlying_shares: As set forth in the Warrant to Purchase Shares of Common Stock of Owlet, Inc., dated February 29, 2024, by the Issuer and Eclipse EGF I (the "Warrant"), the exercise price and the number of shares of the Issuer's Common Stock issuable upon exercise are subject to adjustment upon the occurrence of certain events. As such, the exercise price and the number of shares of Common Stock issuable upon exercise as reported on this Form 4 are subject to change upon the occurrence of future events in accordance with the terms of the Warrant. F5 · ownership.nature: The shares of Series B Convertible Preferred Stock are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Mr. Susan is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 21:31 UTC | Owlet, Inc. OWLT · Entity 6551 | PurchaseSeries B Convertible Preferred Stock · Derivative | 6,000 | $1,000.00 | $6,000,000.00 |
DisclosureSEC source: 0001628280-24-008526 · wk-form4_1709587530.xml · derivative · entry 3 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes. Disclosed balance after: 6,000 Underlying: Common Stock · 777,957 shares Expires not disclosed F3 · derivative.exercise_price: The Series B Convertible Preferred Stock is convertible into shares of Common Stock. The conversion rate shall initially be 129.6596 shares of Common Stock per each share of Series B Convertible Preferred Stock, subject to adjustment from time to time pursuant to the terms and conditions of the Investment Agreement, dated February 25, 2024, by and among the Issuer and Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I"), amongst others. F3 · shares: The Series B Convertible Preferred Stock is convertible into shares of Common Stock. The conversion rate shall initially be 129.6596 shares of Common Stock per each share of Series B Convertible Preferred Stock, subject to adjustment from time to time pursuant to the terms and conditions of the Investment Agreement, dated February 25, 2024, by and among the Issuer and Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I"), amongst others. F4 · derivative.expiration_date: The Series B Convertible Preferred Stock does not have an expiration date. F3 · balance_after: The Series B Convertible Preferred Stock is convertible into shares of Common Stock. The conversion rate shall initially be 129.6596 shares of Common Stock per each share of Series B Convertible Preferred Stock, subject to adjustment from time to time pursuant to the terms and conditions of the Investment Agreement, dated February 25, 2024, by and among the Issuer and Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I"), amongst others. F5 · ownership.nature: The shares of Series B Convertible Preferred Stock are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Mr. Susan is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any. Read SEC document |
| February 17, 2023 Filed Feb 23, 2023 01:46 UTC | Owlet, Inc. OWLT · Entity 6551 | PurchaseWarrants (Right to Purchase Shares of Common Stock) · Derivative | 74,204,080 | Not disclosed Strike: $0.33 | Not disclosed |
DisclosureSEC source: 0001628280-23-004652 · wf-form4_167711678454400.xml · derivative · entry 2 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote. Disclosed balance after: 74,204,080 Underlying: Common Stock · 74,204,080 shares Expires 2028-02-17 F4 · derivative.exercise_price: As set forth in the Warrant to Purchase Shares of Common Stock of Owlet, Inc., dated February 17, 2023, by the Company and Eclipse EGF I, the exercise price and the number of shares of the Company's Common Stock issuable on exercise are subject to adjustment upon the occurrence of certain events. As such, the exercise price and the number of shares of Common Stock issuable upon exercise as reported on this Form 4 are subject to change upon the occurrence of future events in accordance with the terms of the Warrant. F4 · shares: As set forth in the Warrant to Purchase Shares of Common Stock of Owlet, Inc., dated February 17, 2023, by the Company and Eclipse EGF I, the exercise price and the number of shares of the Company's Common Stock issuable on exercise are subject to adjustment upon the occurrence of certain events. As such, the exercise price and the number of shares of Common Stock issuable upon exercise as reported on this Form 4 are subject to change upon the occurrence of future events in accordance with the terms of the Warrant. F4 · price: As set forth in the Warrant to Purchase Shares of Common Stock of Owlet, Inc., dated February 17, 2023, by the Company and Eclipse EGF I, the exercise price and the number of shares of the Company's Common Stock issuable on exercise are subject to adjustment upon the occurrence of certain events. As such, the exercise price and the number of shares of Common Stock issuable upon exercise as reported on this Form 4 are subject to change upon the occurrence of future events in accordance with the terms of the Warrant. F4 · derivative.underlying_shares: As set forth in the Warrant to Purchase Shares of Common Stock of Owlet, Inc., dated February 17, 2023, by the Company and Eclipse EGF I, the exercise price and the number of shares of the Company's Common Stock issuable on exercise are subject to adjustment upon the occurrence of certain events. As such, the exercise price and the number of shares of Common Stock issuable upon exercise as reported on this Form 4 are subject to change upon the occurrence of future events in accordance with the terms of the Warrant. F3 · ownership.nature: The shares of Series A Convertible Preferred Stock are held of record by Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I"). Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Mr. Susan is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EGF GP I and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any. Read SEC document |
| February 17, 2023 Filed Feb 23, 2023 01:46 UTC | Owlet, Inc. OWLT · Entity 6551 | PurchaseSeries A Convertible Preferred Stock · Derivative | 20,200 | $1,000.00 Strike: $1,000.00 | $20,200,000.00 |
DisclosureSEC source: 0001628280-23-004652 · wf-form4_167711678454400.xml · derivative · entry 1 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote. Disclosed balance after: 20,200 Underlying: Common Stock · 41,224,489 shares Expires not disclosed F1 · shares: The Series A Convertible Preferred Stock is convertible into shares of Class A common stock, par value $0.0001 per share (the "Common Stock"), of Owlet, Inc. (the "Company"). The conversion rate shall initially be 2,040.8163 shares of Common Stock per each share of Series A Convertible Preferred Stock, subject to adjustment from time to time pursuant to the terms and conditions of the Investment Agreement, dated February 17, 2023, by and among the Company and Eclipse Early Growth Fund I, L.P., amongst others. F2 · derivative.expiration_date: The Series A Convertible Preferred Stock does not have an expiration date. F1 · balance_after: The Series A Convertible Preferred Stock is convertible into shares of Class A common stock, par value $0.0001 per share (the "Common Stock"), of Owlet, Inc. (the "Company"). The conversion rate shall initially be 2,040.8163 shares of Common Stock per each share of Series A Convertible Preferred Stock, subject to adjustment from time to time pursuant to the terms and conditions of the Investment Agreement, dated February 17, 2023, by and among the Company and Eclipse Early Growth Fund I, L.P., amongst others. F3 · ownership.nature: The shares of Series A Convertible Preferred Stock are held of record by Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I"). Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Mr. Susan is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EGF GP I and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:44 UTC | Lucira Health, Inc. LHDX · Entity 115613 | GrantStock Option (right to buy) · Derivative | 59,459 | $0.00 Strike: $1.85 | $0.00 |
DisclosureSEC source: 0001209191-22-034110 · doc4.xml · derivative · entry 1 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,459 Underlying: Common Stock · 59,459 shares Expires 2032-05-31 F1 · derivative.exercise_date: The shares subject to this option will vest upon the earlier of the one year anniversary of the grant date of June 1, 2022 or immediately prior to the next annual meeting. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 00:03 UTC | Owlet, Inc. OWLT · Entity 6551 | GrantCommon Stock | 14,930,616 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-024843 · form4.xml · nonDerivative · entry 2 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 14,930,616 F1 · price: On July 15, 2021, pursuant to that certain Business Combination Agreement, dated as of February 15, 2021, by and among the Issuer, Project Olympus Merger Sub, Inc. ("Merger Sub") and Owlet Baby Care Inc. ("Owlet Baby Care"), Merger Sub merged with and into Owlet Baby Care with Owlet Baby Care surviving as a wholly owned subsidiary of the Issuer (the "Merger"). Upon consummation of the Merger (the "Effective Time"), each issued and outstanding share of common stock of Owlet Baby Care was automatically cancelled and converted into approximately 2.053 (the "Exchange Ratio") shares of common stock of the Issuer. F3 · ownership.nature: The shares of common stock are held of record by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity I"). Eclipse Continuity GP I, LLC ("Eclipse Continuity GP") is the general partner of Eclipse Continuity I and may be deemed to have voting and dispositive power over the shares held by Eclipse Continuity I. The reporting person is the sole managing member of Eclipse Continuity GP and may be deemed to have voting and dispositive power over the shares held by Eclipse Continuity I. Eclipse Continuity GP and the reporting person disclaim beneficial ownership of the shares held by Eclipse Continuity I except to the extent of their respective pecuniary interests therein, if any. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 00:03 UTC | Owlet, Inc. OWLT · Entity 6551 | GrantCommon Stock | 13,561,716 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-024843 · form4.xml · nonDerivative · entry 1 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 13,561,716 F1 · price: On July 15, 2021, pursuant to that certain Business Combination Agreement, dated as of February 15, 2021, by and among the Issuer, Project Olympus Merger Sub, Inc. ("Merger Sub") and Owlet Baby Care Inc. ("Owlet Baby Care"), Merger Sub merged with and into Owlet Baby Care with Owlet Baby Care surviving as a wholly owned subsidiary of the Issuer (the "Merger"). Upon consummation of the Merger (the "Effective Time"), each issued and outstanding share of common stock of Owlet Baby Care was automatically cancelled and converted into approximately 2.053 (the "Exchange Ratio") shares of common stock of the Issuer. F2 · ownership.nature: The shares of common stock are held of record by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. The reporting person is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and the reporting person disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 00:55 UTC | Lucira Health, Inc. LHDX · Entity 115613 | ConversionConvertible Promissory Note · Derivative | Not disclosed | $0.00 Strike: $13.60 | $6,442,717.58 |
DisclosureSEC source: 0001209191-21-009046 · doc4.xml · derivative · entry 10 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 473,729 shares Expires 2022-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The convertible promissory note automatically converted into shares of the Issuer's Common Stock at the closing of the IPO. F3 · ownership.nature: The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 00:55 UTC | Lucira Health, Inc. LHDX · Entity 115613 | ConversionSeries C Preferred Stock · Derivative | 3,710,257 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-009046 · doc4.xml · derivative · entry 9 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 3,710,257 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F3 · ownership.nature: The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 00:55 UTC | Lucira Health, Inc. LHDX · Entity 115613 | ConversionSeries C Preferred Stock · Derivative | 185,512 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-009046 · doc4.xml · derivative · entry 8 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 185,512 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F2 · ownership.nature: The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 00:55 UTC | Lucira Health, Inc. LHDX · Entity 115613 | ConversionSeries B Preferred Stock · Derivative | 877,445 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-009046 · doc4.xml · derivative · entry 7 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 877,445 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F2 · ownership.nature: The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 00:55 UTC | Lucira Health, Inc. LHDX · Entity 115613 | ConversionSeries A Preferred Stock · Derivative | 976,852 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-009046 · doc4.xml · derivative · entry 6 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 976,852 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F2 · ownership.nature: The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 00:55 UTC | Lucira Health, Inc. LHDX · Entity 115613 | ConversionCommon Stock | 473,729 | $13.60 | $6,442,714.40 |
DisclosureSEC source: 0001209191-21-009046 · doc4.xml · nonDerivative · entry 5 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,183,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · ownership.nature: The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.